Category: Client News
PharmExec | Uncovering Long-Term COVID in Drug Development

How can clinical trials be designed to best study therapies for treating long COVID? As progress is made in addressing the COVID-19 pandemic with vaccines and treatment pathways, reports about the long-term effects of the infection are building. Post-acute Sequelae of SARS-CoV-2 (PASC) (i.e., long COVID, long-term COVID, long-haul COVID) is an umbrella term used […]

Alzheimer’s News Today | ACT-AD Phase 2 Trial Fully Enrolled with Results Expected Next Year

Athira Pharma has completed enrollment in its ACT-AD Phase 2 trial evaluating the safety and efficacy of ATH-1017 in adults with mild-to-moderate Alzheimer’s disease. “The completion of enrollment in our ACT-AD trial is an important step forward in advancing ATH-1017 as a potential new treatment option for patients suffering from Alzheimer’s and other dementias,” Mark Litton, PhD, Athira […]

Benzinga | Humboldt Farms’ Cannabis Coming To A Dispensary Near You: Unrivaled Brands Will Exclusively Distribute California’s Renowned Grower

Unrivaled Brands, Inc. UNRV+ Free Alerts, a multi-state cannabis operator, announced on Monday that it has entered into an exclusive distribution agreement with Humboldt Farms, California’s leading source for organic sun-grown cannabis. As part of the agreement, Unrivaled will be executing all sales and distribution services of Humboldt Farms-branded products, including its hand-selected buds grown on small family farms in Humboldt County. Unrivaled Brands has operations in California, Oregon […]